NanoViricides, Inc. is a global leader in the development of nanomedicine drugs against viruses. Their unique nanoviricide® platform technology defines a novel mechanism enabling first-in-class drugs against viruses.

Biotechnology

NanoViricides

NanoViricides' headquarters in West Haven, CT, United States

Anil R. Diwan

Randall W. Barton

Meeta R. Vyas

Stanley Glick

Paul A. Marks

Todd Rokita

Harmon Aronson

Thomas L. Lentz

Mak Jawadekar

Brian Zucker

The Board and Advisors team at NanoViricides, Inc. provides strategic oversight, expert guidance, and governance to ensure the company's mission of advancing nanomedicine drugs against viruses is achieved. This team leverages a wealth of experience in scientific research, financial management, and corporate leadership to steer the company’s innovative platform technology towards impactful and market-driven solutions.

Board and Advisors

This department focuses on advancing innovation through research initiatives and product development.

Research and Development

The Leadership Team at NanoViricides is responsible for strategic decision-making and oversight of the company’s research and development initiatives, financial management, and scientific direction. Comprising key executives including the VP of R&D, CFO, and Chief Scientific Officers, this team drives the advancement of innovative nanomedicine solutions, ensuring alignment with the company's mission to create first-in-class antiviral therapies.

NanoViricides

Org chart

Board & advisors

Teams

Board and Advisors

Research and Development

Leadership Team

Offices

NanoViricides

Org chart

Board & advisors

Teams

Board and Advisors

Research and Development

Leadership Team

Offices

Related companies